Literature DB >> 11120985

SHV-14, a novel beta-lactamase variant in Klebsiella pneumoniae isolates from Nijmegen, The Netherlands.

M Yuan1, L M Hall, J Hoogkamp-Korstanje, D M Livermore.   

Abstract

Four ceftazidime-resistant isolates of a Klebsiella pneumoniae strain were collected from intensive care unit patients in Nijmegen, The Netherlands. These isolates had TEM-29 and SHV-14 beta-lactamases. SHV-14 is a novel variant, with two substitutions compared with the sequence of SHV-1: Ile8Phe and Arg43Ser. Its gene also had a silent C-->T mutation at nucleotide 481. The SHV-14 enzyme had slightly higher V(max) rates than SHV-1 for oxyimino-aminothiazolyl cephalosporins, but this activity was insufficient for the enzyme to count as an extended-spectrum beta-lactamase.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11120985      PMCID： PMC90280          DOI： 10.1128/AAC.45.1.309-311.2001

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  12 in total

1.  SHV-13, a novel extended-spectrum beta-lactamase, in Klebsiella pneumoniae isolates from patients in an intensive care unit in Amsterdam.

Authors:  M Yuan; L M Hall; P H Savelkoul; C M Vandenbroucke-Grauls; D M Livermore
Journal:  Antimicrob Agents Chemother       Date:  2000-04       Impact factor: 5.191

2.  Sequences of the genes for the TEM-20, TEM-21, TEM-22, and TEM-29 extended-spectrum beta-lactamases.

Authors:  G Arlet; S Goussard; P Courvalin; A Philippon
Journal:  Antimicrob Agents Chemother       Date:  1999-04       Impact factor: 5.191

3.  Cloning of SHV-2, OHIO-1, and OXA-6 beta-lactamases and cloning and sequencing of SHV-1 beta-lactamase.

Authors:  J Mercier; R C Levesque
Journal:  Antimicrob Agents Chemother       Date:  1990-08       Impact factor: 5.191

4.  OHIO-1 beta-lactamase is part of the SHV-1 family.

Authors:  D M Shlaes; C Currie-McCumber; A Hull; I Behlau; M Kron
Journal:  Antimicrob Agents Chemother       Date:  1990-08       Impact factor: 5.191

5.  Nomenclature of TEM beta-lactamases.

Authors:  K Bush; G Jacoby
Journal:  J Antimicrob Chemother       Date:  1997-01       Impact factor: 5.790

6.  Antibiotic resistance and production of extended-spectrum beta-lactamases amongst Klebsiella spp. from intensive care units in Europe.

Authors:  D M Livermore; M Yuan
Journal:  J Antimicrob Chemother       Date:  1996-09       Impact factor: 5.790

Review 7.  A functional classification scheme for beta-lactamases and its correlation with molecular structure.

Authors:  K Bush; G A Jacoby; A A Medeiros
Journal:  Antimicrob Agents Chemother       Date:  1995-06       Impact factor: 5.191

8.  SHV-7, a novel cefotaxime-hydrolyzing beta-lactamase, identified in Escherichia coli isolates from hospitalized nursing home patients.

Authors:  P A Bradford; C Urban; A Jaiswal; N Mariano; B A Rasmussen; S J Projan; J J Rahal; K Bush
Journal:  Antimicrob Agents Chemother       Date:  1995-04       Impact factor: 5.191

9.  Rapid procedure for detection and isolation of large and small plasmids.

Authors:  C I Kado; S T Liu
Journal:  J Bacteriol       Date:  1981-03       Impact factor: 3.490

10.  The active-site-serine penicillin-recognizing enzymes as members of the Streptomyces R61 DD-peptidase family.

Authors:  B Joris; J M Ghuysen; G Dive; A Renard; O Dideberg; P Charlier; J M Frère; J A Kelly; J C Boyington; P C Moews
Journal:  Biochem J       Date:  1988-03-01       Impact factor: 3.857
View more
  5 in total

1.  Discrimination of SHV beta-lactamase genes by restriction site insertion-PCR.

Authors:  A Chanawong; F H M'Zali; J Heritage; A Lulitanond; P M Hawkey
Journal:  Antimicrob Agents Chemother       Date:  2001-07       Impact factor: 5.191

2.  Identification and minisequencing-based discrimination of SHV beta-lactamases in nosocomial infection-associated Klebsiella pneumoniae in Brisbane, Australia.

Authors:  Christopher Howard; Angela van Daal; Gregory Kelly; Jacqueline Schooneveldt; Graeme Nimmo; Philip M Giffard
Journal:  Antimicrob Agents Chemother       Date:  2002-03       Impact factor: 5.191

3.  Effects of phenotype and genotype on methods for detection of extended-spectrum-beta-lactamase-producing clinical isolates of Escherichia coli and Klebsiella pneumoniae in Norway.

Authors:  Ståle Tofteland; Bjørg Haldorsen; Kristin H Dahl; Gunnar S Simonsen; Martin Steinbakk; Timothy R Walsh; Arnfinn Sundsfjord
Journal:  J Clin Microbiol       Date:  2006-11-01       Impact factor: 5.948

4.  Characterization of blaKPC-containing Klebsiella pneumoniae isolates detected in different institutions in the Eastern USA.

Authors:  Andrea Endimiani; Andrea M Hujer; Federico Perez; Christopher R Bethel; Kristine M Hujer; Jennifer Kroeger; Margret Oethinger; David L Paterson; Mark D Adams; Michael R Jacobs; Daniel J Diekema; Gerri S Hall; Stephen G Jenkins; Louis B Rice; Fred C Tenover; Robert A Bonomo
Journal:  J Antimicrob Chemother       Date:  2009-01-20       Impact factor: 5.790

5.  Ambler class A extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. in Canadian hospitals.

Authors:  Michael R Mulvey; Elizabeth Bryce; David Boyd; Marianna Ofner-Agostini; Sara Christianson; Andrew E Simor; Shirley Paton
Journal:  Antimicrob Agents Chemother       Date:  2004-04       Impact factor: 5.191
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.